Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.

Literature DB >> 16

Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.

A J Turner, P E Hick.

Abstract

Mesh：

Substances：

Year: 1975 PMID： 16 DOI： 10.1016/0006-2952(75)90016-7

Source DB: PubMed Journal: Biochem Pharmacol ISSN： 0006-2952 Impact factor: 5.858

× No keyword cloud information.

14 in total

Review 1. The clinically inapparent adrenal mass: update in diagnosis and management.

Authors: Georg Mansmann; Joseph Lau; Ethan Balk; Michael Rothberg; Yukitaka Miyachi; Stefan R Bornstein
Journal: Endocr Rev Date: 2004-04 Impact factor: 19.871

Review 2. Clinical practice. The incidentally discovered adrenal mass.

Authors: William F Young
Journal: N Engl J Med Date: 2007-02-08 Impact factor: 91.245

3. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.

Authors: Martha A Zeiger; Geoffrey B Thompson; Quan-Yang Duh; Amir H Hamrahian; Peter Angelos; Dina Elaraj; Elliott Fishman; Julia Kharlip
Journal: Endocr Pract Date: 2009 Jul-Aug Impact factor: 3.443

4. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.

Authors: Abdurrahman Comlekci; Serkan Yener; Senem Ertilav; Mustafa Secil; Baris Akinci; Tevfik Demir; Levent Kebapcilar; Firat Bayraktar; Sena Yesil; Sevinc Eraslan
Journal: Endocrine Date: 2009-10-30 Impact factor: 3.633

5. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

Authors: S Bovio; A Cataldi; G Reimondo; P Sperone; S Novello; A Berruti; P Borasio; C Fava; L Dogliotti; G V Scagliotti; A Angeli; M Terzolo
Journal: J Endocrinol Invest Date: 2006-04 Impact factor: 4.256

6. The prevalence of adrenal incidentaloma in routine clinical practice.

Authors: Colin Davenport; Aaron Liew; Bryan Doherty; Htet Htet N Win; Hafiza Misran; Sarah Hanna; David Kealy; Fatima Al-Nooh; Amar Agha; Christopher J Thompson; Michael Lee; Diarmuid Smith
Journal: Endocrine Date: 2011-03-10 Impact factor: 3.633

7. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

Authors: F Mantero; M Terzolo; G Arnaldi; G Osella; A M Masini; A Alì; M Giovagnetti; G Opocher; A Angeli
Journal: J Clin Endocrinol Metab Date: 2000-02 Impact factor: 5.958

Review 8. Approach to the patient with an adrenal incidentaloma.

Authors: Lynnette K Nieman
Journal: J Clin Endocrinol Metab Date: 2010-09 Impact factor: 5.958

Review 9. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:
Journal: NIH Consens State Sci Statements Date: 2002 Feb 4-6

10. Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement.

Authors: Leslie S Eldeiry; Jeffrey R Garber
Journal: Endocr Pract Date: 2008-04 Impact factor: 3.443

5 in total

Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.

Review 1. The clinically inapparent adrenal mass: update in diagnosis and management.

Review 2. Clinical practice. The incidentally discovered adrenal mass.

3. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.

4. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.

5. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

6. The prevalence of adrenal incidentaloma in routine clinical practice.

7. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

Review 8. Approach to the patient with an adrenal incidentaloma.

Review 9. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").

10. Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement.

1. Metabolism of daunorubicin by a barbiturate-sensitive aldehyde reductase from rat liver.

2. Kinetics and mechanism of action of aldehyde reductase from pig kidney.

3. Sustained virological response: a milestone in the treatment of chronic hepatitis C.

4. The kinetic mechanism of the major form of ox kidney aldehyde reductase with D-glucuronic acid.

5. Analysis of NHEJ-Based DNA Repair after CRISPR-Mediated DNA Cleavage.